Christopher Gibson
Chief Executive Officer at Recursion Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Recursion Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Pacific Biosciences of California Inc. June 3, 202697.0%
-
Recursion Pharmaceuticals Inc. June 16, 202393.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Recursion Pharmaceuticals Inc. | Derivative conversion | +40,000 | — | — |
| Jun 5, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −40,000 | $3.62 | $144,800 |
| May 22, 2026 | Recursion Pharmaceuticals Inc. | Derivative conversion | +40,000 | — | — |
| May 22, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −40,000 | $3.08 | $123,200 |
| May 15, 2026 | Recursion Pharmaceuticals Inc. | Shares withheld for tax | −22,821 | $3.04 | $69,376 |
| May 7, 2026 | Recursion Pharmaceuticals Inc. | Derivative conversion | +60,000 | — | — |
| May 7, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −40,000 | $3.37 | $134,800 |
| May 7, 2026 | Recursion Pharmaceuticals Inc. | Gift | −20,000 | — | — |
| Apr 22, 2026 | Recursion Pharmaceuticals Inc. | Derivative conversion | +40,000 | — | — |
| Apr 22, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −40,000 | $3.61 | $144,400 |
| Apr 8, 2026 | Pacific Biosciences of California Inc. | Grant or award | +57,473 | — | — |
| Apr 7, 2026 | Recursion Pharmaceuticals Inc. | Derivative conversion | +40,000 | — | — |
| Apr 7, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −40,000 | $3.10 | $124,000 |
| Mar 23, 2026 | Recursion Pharmaceuticals Inc. | Derivative conversion | +40,000 | — | — |
| Mar 23, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −40,000 | $3.25 | $130,000 |
Questions about Christopher Gibson
What boards is Christopher Gibson on?
Christopher Gibson sits on the boards of Pacific Biosciences of California Inc. and Recursion Pharmaceuticals Inc.
What company is Christopher Gibson the CEO of?
Christopher Gibson is Chief Executive Officer of Recursion Pharmaceuticals Inc.
How long has Christopher Gibson served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.